NCT00699894View on ClinicalTrials.gov

Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

aprepitant 40 mg

aprepitant 40 mg PO 1-3 hours prior to surgery

DRUG

ondansetron 4 mg

ondansetron 4 mg IV 2-5 minutes prior to induction of anesthesia

Trial Locations (1)

11040

Long Island Jewish Medical Center/Schneider's Children Hospital, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER